CLINICAL AND PROGNOSTIC ASPECTS OF THE ASSESSMENT OF BRAIN NATRIURETIC PEPTIDE AND GRACE IN PATIENTS WITH ACUTE CORONARY SYNDROME

  • N. P. Kopitsa
  • O. V. Degtyarevа
  • O. V. Petynina
Keywords: acute coronary syndrome, biomarkers, TIMI, GRACE, PURSUIT, NT-proBNP, the fore¬cast repeated coronary events

Abstract

One of the achievements of recent years in the field of cardiology is to create a model for risk assessment of patients with acute coronary syndrome (ACS), which allows you to select the most optimal treatment strate­gy. In clinical practice used models for calculating risk TIMI, GRACE, PURSUIT, based on clinical data, ECG, assessment of biochemical markers. In order to improve forecast accuracy in our study, we used the most popular scale of GRACE in conjunction with indicators of the N-terminal region prohormone brain natriuretic peptide (NT-proBNP) in 126 patients with ACS for short-and long-term prognosis. We found that the highest level of cardiac mortality was observed in patients with indicators GRACE> 4 and at the level of NT-proBNP> 1271 pg / ml.

Downloads

Download data is not yet available.

References

1. Antman E. M., Anbe D. T., Armstrong P. W. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Man¬agement of patients with acute myocardial infarction). J Am Coll Cardiol, – 2004; 44 : E1-E211.

2. Gibbons R. J., Abrams J., Chatterjee K. et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina – summary article: a report of the American College of Cardiolo¬gy / American Heart Association Task Force on Practice Guidelines (Committee on the Management of Pa-tients With Chronic Stable Angina). J Am Coll Cardiol, – 2003; 41 : 159-168.

3. Simon Т., Jaillon P. Hormone replacement therapy in postmenopausal women at cardiovascular risk: epide¬miology and clinical trials. Eur Heart J. – 2000; 2:Suppl G : G2-G6.

4. Simon Т., Mary-Krause M., Funck-Brentano C., Jaillon P. Sex differences in the prognosis of congestive heart failure. Results from the Cardiac Insufficiency Bisoprolol Study (CIBISJI). Circulation. – 2001; 103: 375-380.

5. Hellermann J. P., Jacobsen S. J., Reeder G. S. et al. Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community. Am Heart J, – 2003; 145 : 742-748.

6. Felker G. M., Shaw L. K., O’Connor C. M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol, – 2002 ; 39 : 210-218.

7. Woodfield S. L., Lundergan C. F., Reiner J. S. et al. Gender and acute myocardial infarction: is there a differ¬ence response to thrombolysis? J Am Coll Cardiol, – 1997; 29 : 35-42.

8. Yap Y. G., Doung Т., Bland M. et al. Is there a gender difference in the risk of arrhythmic death after acute myocardial infarction? An insight from contemporary survival studies (abstr.). J Am Coll Cardiol. – 2002; 39 : 326 B.
How to Cite
Kopitsa, N. P., DegtyarevаO. V., & Petynina, O. V. (1). CLINICAL AND PROGNOSTIC ASPECTS OF THE ASSESSMENT OF BRAIN NATRIURETIC PEPTIDE AND GRACE IN PATIENTS WITH ACUTE CORONARY SYNDROME. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (20), 32-36. Retrieved from https://periodicals.karazin.ua/medicine/article/view/6909
Section
Clinical research